Quality of life evaluation of patients with neurogenic bladder submitted to reconstructive urological surgeries preserving the bladder

ABSTRACT

Treatment of neurogenic bladder (BN) aims to upper urinary tract protection. When the conservative clinical measures are insufficient, surgical treatment is indicated. Though admittedly important, the quality of life (QoL) has been little studied in these patients, there are even contradictory results. The aim of this study was to evaluate QoL before and after bladder augmentation in patients with BN refractory to medical treatment. We analyzed, prospectively, the data of 67 patients who underwent surgical treatment for BN by questionnaire SF-36® and Qualiveen® QoL before and after six months of operation. Comparisons using paired t-tests and Wilcoxon and the assumption of normality was assessed using the Shapiro-Wilk test were made. According to the analysis of the SF-36® questionnaire, the patients had higher QoL indices in the postoperative period in the areas functional capacity, general state of health, vitality, social aspects, emotional aspects and mental health (n = 67; p <0.05). The questionnaire also revealed Qualiveen® best result in quality of life index in the postoperative period, and show lower specific negative impact by urinary problems (n = 36; p <0.05). The results show that, despite not being the main objective, the bladder augmentation results in significant improvement in QoL, probably related to the perception of better health and the resolution of urinary incontinence. Thus, the bladder augmentation associated with other urologic reconstruction techniques allows the upper urinary tract protection, and contribute to a better quality of life of patients with BN.

Key words:
Urinary Bladder; Quality of Life; Urinary Bladder, Neurogenic; Postoperative Period

INTRODUCTION

The term “neurogenic bladder” (NB) is employed to describe any disturbance of the bladder-sphincter system caused by or associated to alteration of bladder innervation and of the muscles of the pelvic floor. Among several etiologies, it includes myelomeningocele, spinal cord injury, myelitis, multiple sclerosis and several other conditions that can reduce bladder capacity and compliance (¹).

Bladder neurological alterations are therapeutically challenging, due to high risk of renal failure (²–⁴). Renal failure is the main cause of death among patients with myelomeningocele in all ages (⁵). NB treatment is intended to protect the superior renal tract, to promote urinary continence and, when possible, to preserve micturition. When conservative measures, such as clean intermittent catheterization, the use of anticholinergic drugs and intravesical injection of botulin toxin are insufficient, surgical treatment is indicated (⁶). Although most care centers use bladder augmentation as the primary choice of treatment, cystectomy and ileal conduit are also satisfactory for those patients (⁷).

Evaluation of quality of life (QoL) of patients with NB should always be part of the evaluation of symptoms and follow-up of results of treatments, as observed in other chronic and debilitating conditions (⁸, ⁹). Measurement of QoL is a fundamental parameter of treatment evaluation, since it allows for a multidimensional understanding of the patient's life, including physical, mental, emotional and social well-being. The perspective of deterioration of renal function is an important source of psychological stress, anxiety and reduction of QoL of patients with NB. Despite this, few articles evaluate the impact of surgical treatment on QoL of patients with NB. In literature, there are contradictory results in different casuistries (⁷, ¹⁰–¹³). The objective of the present study was to evaluate QoL before and after reconstructive urological surgeries preserving the bladder in patients with NB refractory to clinical treatment.

MATERIALS AND METHODS

From 2008 to 2012, 67 patients with NB refractory to clinical treatment decided to participate in a study previously approved by the Ethical and Research Committee and were submitted to bladder augmentation and to eventual complementary procedures by the same surgeon; there were 22 female patients (32.8%) and 45 male patients (67.2%), with a median age of 29.5±1.7 years. NB etiology included spinal cord injury (n=33; 49.0%), myelomeningocele (n=24; 35.8%) and myelitis (n=10; 15.2%).

Refractory clinical treatment was stablished when it was observed incapacity to control intravesical pressure, associated or not to deterioration of renal function and to urinary incontinence, using anticholinergic drugs, clean bladder catheterization and intravesical injection of botulin toxin, Exclusion criteria included non-acceptance of participation of the study (two patients). After hospital discharge, patients were followed weekly during the first two months and monthly after six months of surgery.

Prospectively, the data from the generic questionnaire about QoL Short Form Health Survey (SF-36®) were analyzed. The 67 patients filled the questionnaire before and six months after the surgery. Also, 36 patients answered the specific questionnaire for QoL Qualiveen®. The question forms were completed in the ambulatory and were supervised by the physician that performed the surgeries. The question forms were translated and validated to Portuguese (¹⁴, ¹⁵).

The pre and post-operatory data were statistically analyzed by the softwares R, version 2.7.1 and Epi Info version 6.04. Parametric data were analyzed by paired-t test and non-parametric data by Wilcoxon test. Normality assumption was evaluated by the Shapiro-Wilk test. Significance level was established as 5%.

RESULTS

For bladder augmentation it was utilized the distal ileum (n=56; 83.6%), sigmoid colon (n=8; 11.9%) and stomach (n=3; 4.5%). In 14 patients some complementary procedures were performed: cutaneous apendico-vesicostomy (n=7), continent cutaneous ileo-vesicostomy (Yang-Monti technique) (n=2) (¹⁶), unilateral ureteral reimplantation (n=4) and cutaneous apendicostomy (Malone technique) (n=1) (¹⁷). All patients were continent after 6 months of bladder augmentation surgery. In spite of the magnitude of the surgery, only prolonged ileum delayed hospital discharge in some cases. Routinely, a cystostomy catheter was maintained for one week and through it it was instilled a mucolytic solution, preventing urinary obstruction (retention) by mucus.

During the 6 months period of follow-up, there were no episodes of urinary tract infection or surgical wound infection, as well as no clinical metabolic disturbances.

According to the analysis of the SF-36® questionnaire (Table-1), patients presented higher QoL at post-operatory period in the domains functional capacity, general health status, vitality, social aspects, emotional aspects and mental health. The domains physical limitation and pain showed severe intestinal constipation (¹⁷). Ureteral reimplantation was performed in 4 patients with grades IV and V vesico-ureteral reflux in order to protect the superior renal tract. Cases with grades I and II reflux were not surgically corrected due to low correlation with renal failure, following amelioration of bladder capacity (⁹). The choice of gastrointestinal segment was based upon renal function and easiness of technique, in order to move the chosen segment to bladder without tension. Three cases of gastro-cystoplasty were performed in patients with limited renal function, that contraindicated the use of ileum or colon, due to absorptive capacity of intestinal mucosa.

Table 1
Quality of life before and after surgery according to the SF-36® questionnaire.

Domains1	Pre-operatory (n=67)	Post-operatory (n=67)	P
Functional capacity	29.0±26.2	35.0±28.7	0.0243
Physical limitation	33.9±36.6	40.5±41.8	0.0873
Pain	66.6±26.3	70.1±25.2	0.1992
General health	58.9±22.1	67.0±20.4	<0.0012
Vitality	62.7±24.8	67.2±26.1	0.0123
Social aspects	63.8±27.0	72.3±29.0	0.0103
Emotional aspects	44.3±42.0	56.5±41.4	0.0203
Mental health	62.0±24.0	66.3±25.8	0.0093

• ¹
  = Pontuaction limit from 0 to 100;
• ²
  = paired T-test;
• ³
  = Wilcoxon test Values expressed as median±standard deviation

Table 2
Quality of life before and after surgery according to Qualiveen ® questionnaire.

Domains	Pre-operatory (n=36)	Post-operatory (n=36)	P
Inconvenience1	1.82±1.06	1.31±0.96	0.0023
Limitation1	2.78±0.86	2.21±0.98	<0.0014
Fears1	2.25±0.86	1.79±1.04	0.0033
Daily activities impact1	1.97±1.09	1.48±1.01	0.0023
SIUP index1	2.23±0.76	1.70±0.83	<0.0013
QoL index2	0.02±0.90	0.54±0.97	<0.0014

• ¹
  = ponctuation limit from 0-4;
• ²
  = ponctuation limites from-2 to+2;
• ³
  = paired T-test;
• ⁴
  = Wilcoxon test Values expressed as median±standard deviation

The generic question form SF-36® presented higher indexes of QoL at the post-operatory period in all domains, except physical limitation and pain. The use of a specific questionnaire for patients with spinal cord injury (Qualiveen®) completed the QoL evaluation, since generic question forms may not correctly reflect important aspects of physical, social and psychological well-being of these individuals (⁸).

We started the use of (Qualiveen®) only for the last 36 patients, since it was not included in the original project. Since this was a prospective study, the data of the initial patients could not be analyzed. Also, the results of (Qualiveen®) showed lower impact on QoL in all studied domains during post-operatory period. The generic evaluation of QoL included in this instrument was in accordance to the previous relative positive effect of the surgical treatment.

It is important to stress the heterogeneity of the present data in terms of baseline diseases and their evolution period, that varied from a few years (patients with spinal cord injury and myelites), to lifetime (patients with myelomeningoceles). Forms of treatment also varied, in terms of the chosen gastrointestinal segment and of the need of the construction of continent conduits for catheterization. However, in order to unify the samples, bladder augmentation surgery was performed as primary surgical procedure and all patients presented bladder disturbances, including low compliance, elevated pressures and low capacity of storage. Although there were differences, better quality of life was observed in all individuals, even in those without urinary incontinence in the pre-operatory period. These aspects corroborate the perception that health status is benefitted by reconstructive urological surgeries with bladder preservation.

Probably, there was better urinary continence during catheterization intervals, since this is a troublesome alteration in all patients. Urinary continence probably benefitted secondarily social life and allowed for the performance of daily activities, as noted by the questionnaires. Patients submitted to continent conduit for catheterization were able to empty more easily their bladder, with a better QoL, since the difficulty during pre-operatory period to catheterize was corrected. Interval spaces between catheterization were corrected allowing for the avoidance of urinary leakage. The absence of alteration of the SF0360® domains physical limitation and pain after surgery is predictable, since the surgical procedures were directed to the urinary tract problems.

QoL improvement during post-operatory period in patients with NB refractory to clinical treatment was also observed in previous studies (⁷, ¹³). Although this correlation seems obvious, the absence of QV improvement following surgeries for urinary incontinence of patients with NB was also published (¹²). Since QoL is a concept that includes social, psychological and physical aspects, different populations can experience these aspects differently, and it is important to perform studies in different centers (¹²). Although cystectomy and ileum conduit also present good results in terms of QoL (⁷), this technique present long term clinical risks, such as renal failure, and has been deprecated by most authors (¹⁹). Bladder augmentation associated to other techniques of urological reconstruction remains an excellent choice for NB patients, although without side effects as the presence of mucus in the urine and the need of intermittent catheterization (²⁰). Being less aggressive and without an incontinent abdominal stoma, it is preferred in relation to cystectomy. Future studies may discriminate better the implied factors related to QoL improvement in patients submitted to reconstructive urological surgeries and contribute to better choice of therapies for this complex condition.

CONCLUSIONS

Surgical treatment of NB refractory to clinical treatment using reconstructive techniques in order to preserve the bladder is associated with improvement of QoL indexes at post-operatory period, according to the SF-36® and Qualiveen® questionnaires.

REFERENCES

• ¹
  Fowler CJ, Dalton C, Panicker JN. Review of neurologic diseases for the urologist. Urol Clin North Am. 2010;37:517-26.
• ²
  Hackler RH. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol. 1977;117:486-8.
• ³
  Geisler WO, Jousse AT, Wynne-Jones M, Breithaupt D. Survival in traumatic spinal cord injury. Paraplegia. 1983;21:364-73.
• ⁴
  Webb DR, Fitzpatrick JM, O’Flynn JD. A 15-year follow-up of 406 consecutive spinal cord injuries. Br J Urol. 1984;56:614–7.
• ⁵
  Woodhouse CR. Myelomeningocele in young adults. BJU Int. 2005;95:223-30.
• ⁶
  Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord. 2000;38:490-4.
• ⁷
  Guillotreau J, Castel-Lacanal E, Roumiguié M, Bordier B, Doumerc N, De Boissezon X, et al. Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction. Neurourol Urodyn. 2011;30:1503-6.
• ⁸
  Ku JH. The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int. 2006;98:739-45.
• ⁹
  Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56:81-8.
• ¹⁰
  Kuo HC. Clinical outcome and quality of life after enterocystoplasty for contracted bladders. Urol Int. 1997;58:160-5.
• ¹¹
  Kuo HC. Quality of life after active urological management of chronic spinal cord injury in eastern Taiwan. Eur Urol. 1998;34:37-46.
• ¹²
  MacNeily AE, Jafari S, Scott H, Dalgetty A, Afshar K. Health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol. 2009;182:1984-91.
• ¹³
  Vajda P, Kispal Z, Lenart I, Farkas A, Vastyan AM, Pinter AB. Quality of life:urinary bladder augmentation or substitution in children. Pediatr Surg Int. 2009;25:195-201.
• ¹⁴
  Campolina AG, Ciconelli RM. [SF-36 and the development of new assessment tools for quality of life]. Acta Reumatol Port. 2008;33:127-33.
• ¹⁵
  D’Ancona CA, Tamanini JT, Botega N, Lavoura N, Ferreira R, Leitão V, et al. Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen. Int Urol Nephrol. 2009;41:29-33.
• ¹⁶
  Monti PR, Lara RC, Dutra MA, de Carvalho JR. New techniques for construction of efferent conduits based on the Mitrofanoff principle. Urology. 1997;49:112-5.
• ¹⁷
  Malone PS, Ransley PG, Kiely EM. Preliminary report: the antegrade continence enema. Lancet. 1990 17;336:1217-8.
• ¹⁸
  Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermitente self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107:458-61.
• ¹⁹
  Westney OL. The neurogenic bladder and incontinent urinary diversion. Urol Clin North Am. 2010;37:581-92.
• ²⁰
  Mast P, Hoebeke P, Wyndaele JJ, Oosterlinck W, Everaert K. Experience with augmentation cystoplasty. A review. Paraplegia. 1995;33:560-4.

Publication Dates

• Publication in this collection
  May-Jun 2015

History

• Received
  23 Mar 2014
• Accepted
  30 Nov 2014